SCHEMBL29327043

SCHEMBL29327043

Nc1cc([C@@H]2CCOC2)[nH]n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
DAO P14920 1/20 0.38
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
PRKAB2 O43741 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAG3 Q9UGI9 1/20 0.34
PRKAG2 Q9UGJ0 1/20 0.34
PRKAB1 Q9Y478 1/20 0.34
HCAR2 Q8TDS4 3/20 0.34
HCAR3 P49019 1/20 0.32
PIK3CA P42336 1/20 0.30
PDPK1 O15530 1/20 0.30
PIK3C3 Q8NEB9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14722728 1.00 PRMT5 (0.40) PRMT5WDR77DAOMKNK1MKNK2
SCHEMBL31080297 0.90 HCAR2 (0.37) PRMT5WDR77MKNK1MKNK2HCAR2
SCHEMBL4016705 0.89 DAO (0.47) PRMT5WDR77DAOMKNK1MKNK2
SCHEMBL14722873 0.85 MKNK1 (0.35) MKNK1MKNK2HCAR2HCAR3PDPK1
SCHEMBL18403239 0.79 DAO (0.38) PRMT5WDR77DAOPRKAB2PRKAG1
SCHEMBL15882695 0.79 DAO (0.38) PRMT5WDR77DAOPRKAB2PRKAG1
SCHEMBL56939 0.79
Hydrochloric Acid SCHEMBL17107724 0.77 HCAR2 (0.48) DAOMKNK1MKNK2HCAR2HCAR3
SCHEMBL3551909 0.76 HCAR2 (0.49) DAOMKNK1MKNK2HCAR2HCAR3
SCHEMBL1269829 0.76 HCAR2 (0.53) DAOMKNK1MKNK2HCAR2HCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646414-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2025-11-12 EP disclosed
WO-2024148091-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-07-11 WO disclosed
WO-2024148091-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-07-11 WO disclosed